Latest filing published 31 Mar 2026 for Avalo Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Jonathan Goldman: trading record in brief
All filings by Jonathan Goldman on record concern Avalo Therapeutics, Inc. We count 5 filings; the first trade dates from 28 March 2025 and the latest from 28 March 2026.
On the market, this insider has only sold: 2 sales, €140k in total. Besides market trades, the filings include 3 option exercises.
The record was last updated on 31 March 2026 with an option exercise in Avalo Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jonathan Goldman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,166 sharesCommon StockSEC:0002013869-26-000002:0
- 8,200 shares@ US$9.8833.2% of flowCommon StockSEC:0002013869-25-000002:1
- 8,200 shares@ US$14.3548.2% of flowCommon StockSEC:0002013869-25-000002:2
- 3,167 shares@ US$14.30100.0% of flowCommon StockSEC:0002013869-25-000002:0
- 3,167 sharesCommon StockSEC:0001578563-25-000203:0
5 of 5 declarations
